Dong-A ST Rises 0.92% Amid Uptrend in Biosimilar (Generic Biopharmaceutical) Theme

On the 21st, the biosimilar (replicated biopharmaceutical) theme showed strength by rising 3.06% compared to the previous day, while Dong-A ST, a related stock attracting attention, surged by 0.92% compared to the previous day. Dong-A ST is known as a pharmaceutical company listed through a corporate spin-off from Dong-A Pharmaceutical.

[Graph] Major stock price changes in the biosimilar (replicated biopharmaceutical) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Dong-A ST ranked first in the quant financial ranking (out of 17 stocks) by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Dong-A ST having a higher investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.